Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Topic or Issue
Home Search/Browse Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 22, No 14S (July 15 Supplement), 2004: 7326
© 2004 American Society of Clinical Oncology
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaena, D. A.
Right arrow Articles by Loehrer, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vaena, D. A.
Right arrow Articles by Loehrer, P.

Abstract

Novel association between thymomas and T-cell Non-Hodgkin's lymphomas: Evaluation of 5 cases

D. A. Vaena, M. Czader, E. Van Hook, K. Ganjoo and P. Loehrer

Indiana University, Indianapolis, IN

7326

Background: Thymomas are often accompanied by a variety of paraneoplastic syndromes and have been associated with abnormal intra-thymic T-cell development, as well as oligoclonal T-cell populations in the bone marrow of certain patients. Prior series have shown an increased incidence of secondary malignancies in patients with thymoma. Recently, Engels et al. (Int. J. Cancer: 105, 546–551) demonstrated an excessive occurrence of Non-Hodgkin's lymphomas (NHL) after a thymoma diagnosis, identifying 7 cases among 9 SEER registries; however, only B-cell NHL cases were found. We report the association between thymomas and T-cell NHLs and examine its possible causal relationship to abnormal T-cell maturation within the thymus, employing immunohistochemical stains and assessment of T-cell clonality. Methods: Five patients with thymoma and T-cell NHL (both biopsy-proven) were identified through the Thymoma Clinic database at Indiana University. The T-NHL diagnosis could precede, concur or be subsequent to the thymoma. Original thymic samples are being stained for CD2, CD3, CD5, CD4, CD8, CD25, CDK6, p53 and compared to NHL samples. Thymic T-lymphocytes and original T-NHL lymphocytes are being subjected to T-cell receptor gene rearrangement studies by PCR. Results: Median age at the time of thymoma diagnosis was 38 years (range, 28–56). Patient characteristics are summarized in the table. All patients had cortical thymoma. Two patients (cases 4 and 5) presented with the T-NHL in the setting of persistent thymoma. Conclusions: We describe a novel clinical association between thymomas and T-cell NHLs. Abnormal T-cell maturation induced by thymomas may play a role in T-NHL pathogenesis in these patients. Correlative studies will be available for presentation at the time of the Annual Meeting.



View larger version (20K):
[in this window]
[in a new window]
 
 
No significant financial relationships to disclose.






About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
HighWire Press HighWire Press™ assists in the publication of JCO Online